In a worrying situation, manufacturing plant of Cadila Pharmaceuticals in Ahmedabad has been closed after 26 of its employees tested positive for the coronavirus.
The firm has initiated sanitisation of the plant and its surroundings.
"Manufacturing plant of Cadila Pharmaceuticals at Dholka in Ahmedabad, Gujarat has been closed following 26 of its employees testing positive for COVID-19. Deep sanitization of the plant & its surroundings is being undertaken," the statement from Cadila Pharmaceuticals read.
More details in this regard are awaited.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)